Regulation of lens aldose reductase activity by nitric oxide

Experimental Eye Research

Volumn 81, Issue 6, 2005, Pages 664-672

  Srivastava, Seema ^a   Tammali, Ravinder ^a   Chandra, Deepak ^a   Greer, Deborah A ^a   Ramana, Kota V ^a   Bhatnagar, Aruni ^b   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Aldose reductase; Diabetes; Lens; Nitric oxide; Sorbitol

Indexed keywords

ALDEHYDE REDUCTASE; ARGININE; CELL PROTEIN; GLUTATHIONE DERIVATIVE; GLYCERYL TRINITRATE; N ACETYLPENICILLAMINE; NITRIC OXIDE; SORBITOL; STREPTOZOCIN;

ARTICLE; BIOACCUMULATION; BIOAVAILABILITY; CATARACTOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; LENS; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM;

ALDEHYDE REDUCTASE; ANIMALS; CELL LINE, TRANSFORMED; CELLS, CULTURED; CRYSTALLINS; DIABETES MELLITUS, EXPERIMENTAL; EPITHELIAL CELLS; GLUTATHIONE; HUMANS; LENS, CRYSTALLINE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SORBITOL;

EID: 29144533292     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.04.004     Document Type: Article

References (43)

1. V.M. Altan, C. Karasu, and A. Ozuari The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta Pharmacol. Biochem. Behav. 33 1989 519 522
2. J.W. Baynes, and S.R. Thorpe Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 48 1999 1 9
3. A. Bhatnagar, and S.K. Srivastava Aldose reductase: Congenial and injurious profiles of an enigmatic enzyme Biochem. Med. Metabol. Biol. 48 1992 91 121
4. A. Bhatnagar, S. Liu, B. Das, and S.K. Srivastava Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction Mol. Pharmacol. 36 1989 825 830
5. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
6. M. Cappiello, M. Voltarelli, M. Giannessi, I. Cecconi, G. Camici, G. Manao, A. Del Corso, and U. Mura Glutathione dependent modification of bovine lens aldose reductase Exp. Eye Res. 58 1994 491 501
7. M. Cappiello, M. Voltarelli, I. Cecconi, P.G. Vilardo, M. Dal Monte, I. Marini, A. Del Corso, D.K. Wilson, F.A. Quiocho, J.M. Petrash, and U. Mura Specifically targeted modification of human aldose reductase by physiological disulfides J. Biol. Chem. 271 1996 33539 33544
8. A. Chandra, S. Srivastava, J.M. Petrash, A. Bhatnagar, and S.K. Srivastava Modification of Aldose reductase by S-nitrosoglutathione Biochemistry 36 1997 15801 15809
9. D. Chandra, E.B. Jackson, K.V. Ramana, R. Kelley, S.K. Srivastava, and A. Bhatnagar Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes Diabetes 51 2002 3095 3101
10. S.H. Chiou, C.J. Chang, C.K. Chou, W.M. Hsu, J.H. Liu, and C.H. Chiang Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma Diabetes Care 22 1999 861 862
11. L.J. Coppey, J.S. Gellett, and M.A. Yorek Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: effect of diabetes in type 1 and type 2 diabetic rat models Endothelium 10 2003 89 94
12. M. Daimon, K. Sugiyama, T. Saitoh, H. Yamaguchi, A. Hirata, H. Ohnuma, M. Igarashi, H. Eguchi, H. Manaka, and T. Kato Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes Diabetes Care 23 2000 559 560
13. P.S. Devamanoharan, M. Henein, S. Morris, S. Ramachandran, R. Richards, and S.D. Varma Prevention of selenite cataract by vitamin C Exp. Eye Res. 52 1991 563 568
14. B.L. Dixit, G.K. Balendiran, S.J. Watowich, S. Srivastava, K.V. Ramana, J.M. Petrash, A. Bhatnagar, and S.K. Srivastava Kinetic and structural characterization of the glutathione-binding site of aldose reductase J. Biol. Chem. 275 2000 21587 21595
15. B.L. Dixit, K.V. Ramana, D. Chandra, E.B. Jackson, S. Srivastava, A. Bhatnagar, and S.K. Srivastava Metabolic regulation of aldose reductase activity by nitric oxide donors Chem. Biol. Interact. 130-132 2001 573 581
16. E. Dvornik, N. Simard-Duquesne, M. Krami, K. Sestanj, K.H. Gabbay, J.H. Kinoshita, S.D. Varma, and L.O. Merola Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor Science 182 1973 1146 1148
17. K.E. Fayers, M.H. Cummings, K.M. Shaw, and D.W. Laight Nitrate tolerance and the links with endothelial dysfunction and oxidative stress Br. J. Clin. Pharmacol. 56 2003 620 628
18. M.T. Gewaltig, and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc. Res. 55 2002 250 260
19. M.E. Inkster, M.A. Cotter, and N.E. Cameron Effects of trientine, a metal chelator, on defective endothelium-dependent relaxation in the mesenteric vasculature of diabetic rats Free Radic. Res. 36 2002 1091 1099
20. M. Inomata, M. Hayashi, S. Shumiya, S. Kawashima, and Y. Ito Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in Shumia cataract rats (SCR) J. Biochem. 128 2000 771 776
21. M. Inomata, M. Hayashi, S. Shumiya, S. Kawashima, and Y. Ito Involvement of inducible nitric oxide synthase in cataract formation in Shumiya cataract rat (SCR) Curr. Eye Res. 23 2001 307 311
22. Y. Ito, T. Nabekura, M. Nakao, M. Terao, R. Hori, and M. Tomohiro Nitric oxide participates in cataract development in selenite-treated rats Curr. Eye Res. 22 2001 215 220
23. R.G. Judzewitsch, J.B. Jaspan, K.S. Polonsky, C.R. Weinberg, J.B. Halter, E. Halar, M.A. Pfeifer, C. Vukadinovic, L. Bernstein, M. Schneider, K.Y. Liang, K.H. Gabbay, A.H. Rubenstein, and D. Porte Jr. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients N. Engl. J. Med. 308 1983 119 125
24. C.L. Kao, C.K. Chou, D.C. Tsai, W.M. Hsu, J.H. Liu, C.S. Wang, J.C. Lin, C.C. Wu, C.H. Peng, C.J. Chang, C.L. Kao, and S.H. Chiou Nitric oxide levels in the aqueous humor in cataract patients J. Cataract Refract. Surg. 28 2002 507 512
25. J.H. Kinoshita A thirty year journey in the polyol pathway Exp. Eye Res. 50 1990 567 573
26. E.M. Kurowska Nitric oxide therapies in vascular diseases Curr. Pharm. Des. 8 2002 155 166
27. A.Y. Lee, S.K. Chung, and S.S. Chung Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens Proc. Natl Acad. Sci. USA 92 1995 2780 2784
28. H. Li, Z.M. Marshall, and A.R. Whorton Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels Am. J. Physiol. 276 1999 803 811
29. S.Q. Liu, A. Bhatnagar, B. Das, and S.K. Srivastava Functional cysteinyl residues in human placental aldose reductase Arch. Biochem. Biophys. 275 1989 112 121
30. S.Q. Liu, A. Bhatnagar, and S.K. Srivastava Carboxymethylation-induced activation of bovine lens aldose reductase Biochim. Biophys. Acta 1120 1992 329 336
31. S.Q. Liu, A. Bhatnagar, N.H. Ansari, and S.K. Srivastava Identification of the reactive cysteine residue in human placenta aldose reductase Biochim. Biophys. Acta 11643 1993 268 272
32. M. Lorenzi, S. Toledo, G.R. Boss, M.J. Lane, and D.F. Montisano The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrations Diabetologia 30 1987 222 227
33. S. Marsili, R.I. Salganik, C.D. Albright, C.D. Freel, S. Johnsen, R.L. Peiffer, and M. Joseph Costello Cataract formation in a strain of rats selected for high oxidative stress Exp. Eye Res. 79 2004 595 612
34. T. Nabekura, Y. Koizumi, M. Nakao, M. Tomohiro, M. Inomata, and Y. Ito Delay of cataract development in hereditary cataracts UPL rats by disulfiram and aminoguanidine Exp. Eye Res. 76 2003 169 174
35. S. Pennathur, and J.W. Heinecke Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy Front. Biosci. 9 2004 565 574
36. K.V. Ramana, B.L. Dixit, S. Srivastava, G.K. Balendiran, S.K. Srivastava, and A. Bhatnagar Selective recognition of glutathiolated aldehydes by aldose reductase Biochemistry 39 2000 12172 12180
37. K.V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, and S.K. Srivastava Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells FASEB J. 17 2003 417 425
38. M. Sakurai, T. Higashide, H. Takeda, and Y. Shirao Characterization and diabetes-induced impairment of nitric oxide synthase in rat choroid Curr. Eye Res. 24 2002 139 146
39. S.K. Srivastava, G.A. Hair, and B. Das Activated and unactivated forms of human erytrocyte aldose reductase Proc. Natl Acad. Sci. USA 82 1985 7222 7226
40. S. Srivastava, S.J. Watowich, J.M. Petrash, S.K. Srivastava, and A. Bhatnagar Structural and kinetic determinants of aldehyde reduction by aldose reductase Biochemistry 38 1999 42 54
41. S. Srivastava, B.L. Dixit, K.V. Ramana, A. Chandra, D. Chandra, A. Zacarias, J.M. Petrash, A. Bhatnagar, and S.K. Srivastava Structural and kinetic modifications of aldose reductase by S-nitrosothiols Biochem. J. 358 2001 111 118
42. P.J. Stewart-DeHann, M. Sanwal, M.O. Creighton, W.R. Inch, and J.R. Trevithick 51Cr release and oxidative stress in the lens Lens Eye Toxic. Res. 6 1989 183 202
43. S.R. Thomas, K. Chen, and J.F. Keaney Jr. Oxidative stress and endothelial nitric oxide bioactivity Antioxid Redox Signal. 5 2003 181 194